Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 109, Issue 5, Pages 1214-1222
Publisher
Springer Nature
Online
2013-08-07
DOI
10.1038/bjc.2013.451
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
- (2012) Jolieke G van Oosterwijk et al. BMC CANCER
- Global tumor protein p53/p63 interactome
- (2012) Yiping Huang et al. CELL CYCLE
- PI3K-independent AKT activation in cancers: A treasure trove for novel therapeutics
- (2012) Kiran Mahajan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance
- (2011) J. G. van Oosterwijk et al. ANNALS OF ONCOLOGY
- The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro
- (2011) Philipp Lechler et al. BMC CANCER
- Dasatinib combined with docetaxel for castration-resistant prostate cancer
- (2011) John C. Araujo et al. CANCER
- Curcumin Modulates MicroRNA-203-Mediated Regulation of the Src-Akt Axis in Bladder Cancer
- (2011) S. Saini et al. Cancer Prevention Research
- MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function
- (2011) S Donzelli et al. CELL DEATH AND DIFFERENTIATION
- Inhibition of Src Family Kinases and Receptor Tyrosine Kinases by Dasatinib: Possible Combinations in Solid Tumors
- (2011) J. C. Montero et al. CLINICAL CANCER RESEARCH
- Small-molecule inhibitors of the PI3K signaling network
- (2011) Colleen R McNamara et al. Future Medicinal Chemistry
- IGF-I enhances α5β1 integrin expression and cell motility in human chondrosarcoma cells
- (2011) Chi-Ming Wu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
- (2011) M Fernanda Amary et al. JOURNAL OF PATHOLOGY
- Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome
- (2011) Twinkal C Pansuriya et al. NATURE GENETICS
- Expression of ezrin, Bcl-2, and Ki-67 in chondrosarcomas
- (2010) MIRVA SÖDERSTRÖM et al. APMIS
- First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia
- (2010) F. Ravandi et al. BLOOD
- Fyn
- (2010) Yoshihito D. Saito et al. CANCER
- Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity in Both p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibiting the Akt Pathway
- (2010) G. Zauli et al. CLINICAL CANCER RESEARCH
- Anti-leukemic activity of Dasatinib in both p53wild-type and p53mutated B malignant cells
- (2010) Raffaella Bosco et al. INVESTIGATIONAL NEW DRUGS
- Prolactin Enhances Insulin-like Growth Factor I Receptor Phosphorylation by Decreasing Its Association with the Tyrosine Phosphatase SHP-2 in MCF-7 Breast Cancer Cells
- (2010) Kristopher C. Carver et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- GSK-3β promotes cell survival by modulating Bif-1-dependent autophagy and cell death
- (2010) Jun Yang et al. JOURNAL OF CELL SCIENCE
- Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment
- (2009) Y. M. Schrage et al. CANCER RESEARCH
- Roles of Fyn in pancreatic cancer metastasis
- (2009) Zhi-Yu Chen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The Role of Src in Solid Tumors
- (2009) D. L. Wheeler et al. ONCOLOGIST
- FYNis overexpressed in human prostate cancer
- (2008) Edwin M. Posadas et al. BJU INTERNATIONAL
- Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabinein vitro
- (2008) Lilian Amrein et al. BRITISH JOURNAL OF HAEMATOLOGY
- The Clinical Approach Towards Chondrosarcoma
- (2008) H. Gelderblom et al. ONCOLOGIST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now